Biopharma Business

Tag "launch"

Mundipharma to launch Mabthera biosimilar in EU markets

Mundipharma is gearing up to launch biosimilar Truxima in seven European markets for the treatment of certain cancers and inflammatory conditions, after Celltrion bagged a regulatory approval for the drug.

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here